APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $42.1M invested in Aptevo Therapeutics in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.26M

Top Sellers

1
-$4.22M
2
-$3.12M
3
-$798K
4
Renaissance Technologies
Renaissance Technologies
New York
-$554K
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$404K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$27.2M
2
$4.34M
3
$3.26M
4
$2.21M
5
$2.09M
6
$856K
7
$616K
8
$351K
9
$242K
10
$237K
11
$211K
12
$170K
13
$169K
14
$60K
15
$25K
16
$24K
17
$18K
18
$4K
19
$3K
20
$2K
21
$1K
22
–
23
–
24
–
25
–
1
2